Home
About
Pricing
Log In
Back
AQN
Asset Logo

Aquirian Limited

πŸ‡¦πŸ‡Ί ASX

πŸ‘” PROFESSIONAL SERVICES

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

+ 20.27%
Annual Growth

4 years average annual capital growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

6
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Aquirian Ltd. Is a mining services company, which engages in the provision of equipment, workforce, and innovative products. The company is headquartered in Perth, Western Australia. The company went IPO on 2021-07-27. The firm's principal activities include the development of technology and products, provision of energetic products and services, provision of equipment, onsite field services, workforce, and training solutions to the mining and resources industry. Its segments include Mining Services and People Services. The Mining Services segment provides energetic products and services, consumable products, blasting products and leasing equipment, onsite field services as well as manufacturing storage solutions for explosive materials and dangerous goods. The People Services segment provides personnel on a permanent, casual or contract basis and the training of individuals within the drill and blast-focused industry. Western Energetics Pty Ltd, a wholly owned subsidiary of the Company, operates a facility offering storage, logistics, and energetic solutions.

πŸ“ˆ Performance

Price History

+85.00%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$0.37

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in AQN

6

πŸ“Š Total Capital Earnings

$3K

πŸ”ƒ Average investment frequency

21 weeks

πŸ’΅ Average investment amount

$2,637

⏰ Last time a customer invested in AQN

3 days
AQN investor breakdown
πŸ’΅ Income of investors

More than 200k

20%

150k - 200k

100k - 150k

50k - 100k

40%

Less than 50k

40%
πŸ‘Ά Age of investors

18 - 25

26 - 34

17%

35 - 90

83%
πŸ™‹ Legal gender of investors

Female

17%

Male

83%

Pearlers who invest in AQN also invest in...

iShares S&P 500 ETF

IVV

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

πŸ™Œ Performance (5Yr p.a)

23.01%

πŸ“Š Share price

$67.95 AUD

πŸ“ˆ HIGH PRICE GROWTH

πŸ‡ΊπŸ‡Έ UNITED STATES

Find Out More

Antipa Minerals Ltd. engages in the exploration and development of mineral properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2011-04-20. Its tenement holding covers over 5,100 square kilometers (km2) situated within an underexplored gold-copper-silver-cobalt province. The 100%-owned Minyari Dome Project area covers over 900 km2 and hosts the Minyari and WACA gold-copper-silver-cobalt deposits. The company has three growth projects covering a total of 4,200 km2, including Citadel Project, Wilki Project and Paterson Project. The Wilki Project comprises approximately 1,470km2 in total landholding and is located on the southern portion of its tenement ground in the Paterson Province of Western Australia. The Paterson Project comes to within 22 km of Newmont’s Telfer gold-copper mine and 8km of Rio Tinto’s Winu copper-gold-silver development project. The 1,200 km2 Citadel JV Project adjoins its Paterson Project and includes the Magnum Dome, an area of approximately 30km2.

πŸ™Œ Performance (5Yr p.a)

250.00%

πŸ“Š Share price

$0.68 AUD

⛏️ MINING

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

17.88%

πŸ“Š Share price

$152.35 AUD

πŸ€– TECHNOLOGY

πŸ“ˆ HIGH PRICE GROWTH

🌏 GLOBAL

⛳️ DIVERSIFIED

NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.

πŸ™Œ Performance (5Yr p.a)

22.07%

πŸ“Š Share price

$55.57 AUD

πŸ“ˆ HIGH PRICE GROWTH

πŸ‡ΊπŸ‡Έ UNITED STATES

πŸ€– TECHNOLOGY

Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the provision of business of researching and developing dermatology and antimicrobial products. The company is headquartered in Perth, Western Australia. The Company’s lead product is Sofdra (sofpironium) topical gel, 12.45%, a prescription anticholinergic medicine used on the skin (topical), to treat excessive underarm sweating (primary axillary hyperhidrosis) in adults and children nine years of age and older. Sofdra regulates sweating at the site of application, by binding to the primary sweat receptor and thereby blocking the sweat signal. Its product pipeline targets the various skin diseases, such as BTX 1503 for Acne, BTX 1702 for Rosacea, BTX 1204A for Atopic Dermatitis, and BTX 1801 for Hemodialysis Patients. Its BTX 1503 is a transdermal gel formulation for the treatment of serious acne in adults and teenagers. BTX 1702 is used for the treatment of papulopustular rosacea. BTX 1801 is an antimicrobial gel focused on targeting Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus (MRSA).

πŸ™Œ Performance (5Yr p.a)

13.67%

πŸ“Š Share price

$0.17 AUD

πŸ“¦ LOGISTICS

πŸ“ˆ HIGH PRICE GROWTH

Want more shares? Try these...

Compare
Add to watchlist